Title:
THERAPEUTIC AGENT FOR ACUTE HERPES ZOSTER PAIN
Document Type and Number:
WIPO Patent Application WO/2020/054872
Kind Code:
A1
Abstract:
[Problem] To provide a therapeutic agent for acute herpes zoster pain. [Solution] A therapeutic agent for acute herpes zoster pain, which comprises as an active ingredient a hydantoin compound selected from the group consisting of phenytoin, fosphenytoin, mephenytoin, nirvanol, amino(diphenylhydantoin) valeric acid and ethotoin, and a medicinal composition.
Inventors:
TAKASAKI ICHIRO (JP)
SHIOMURA JIN (JP)
ARAI SAORI (JP)
KITADA YOSHIMI (JP)
SHIMIZU KENJI (JP)
SHIOMURA JIN (JP)
ARAI SAORI (JP)
KITADA YOSHIMI (JP)
SHIMIZU KENJI (JP)
Application Number:
PCT/JP2019/036240
Publication Date:
March 19, 2020
Filing Date:
September 13, 2019
Export Citation:
Assignee:
UNIV OF TOYAMA (JP)
NOBELPHARMA CO LTD (JP)
NOBELPHARMA CO LTD (JP)
International Classes:
A61K31/4166; A61K31/675; A61P25/04; A61P31/22
Domestic Patent References:
| WO2001000191A2 | 2001-01-04 |
Foreign References:
| JP2001500121A | 2001-01-09 |
Other References:
AHMED, A. ET AL.: "Vericella Zoster Virus: structure, mode of transmission and treatment", LIFE SCIENCE JOURNAL, vol. 14, no. 12, 2017, pages 96 - 103, XP055692263
MURAKAWA, KAZUSHIGE ET AL.: "Herpes zoster and postherpetic neuralgia", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 223, no. 9, 2007, pages 747 - 752
DE QUEIROZ, R. B. ET AL.: "Antinoiciceptive effect of Hydantoin 3-Phenyl-5-(4-ethylphenyl)- imidazolidine-2,4-dione in mice", MOLECULES, vol. 20, no. 1, 2015, pages 974 - 986, XP055692264
MURAKAWA, KAZUSHIGE ET AL.: "Herpes zoster and postherpetic neuralgia", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 223, no. 9, 2007, pages 747 - 752
DE QUEIROZ, R. B. ET AL.: "Antinoiciceptive effect of Hydantoin 3-Phenyl-5-(4-ethylphenyl)- imidazolidine-2,4-dione in mice", MOLECULES, vol. 20, no. 1, 2015, pages 974 - 986, XP055692264
Download PDF: